Os TherapiesOSTX
13F holders, Q2 2025 (June 30)13holders +7
7new positions
0sold out
$1.88avg. 13F price*
At the end of Q2 2025, 13 institutions reported holding Os Therapies Inc. (OSTX) in their 13F filings, up 7 from Q1 2025. 7 opened new positions and 0 sold out. The largest holders were CM Management, LLC ($705K), UBS Group AG ($99K) and Ingalls & Snyder LLC ($69K).
- Company
- Os Therapies Inc.
- CUSIP
- 68764Y207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $274K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 221,667 shares bought and 7,226 shares sold, net +214,441 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| CM Management, LLC | 0.64% | Add +25.0% | 375,000 | $705K |
| UBS Group AG | 0.00% | New | 52,817 | $99K |
| Ingalls & Snyder LLC | 0.00% | No change | 36,676 | $69K |
| XTX Topco Ltd | 0.00% | New | 33,489 | $63K |
| BlackRock, Inc. | 0.00% | Reduce -19.3% | 30,281 | $57K |
| Bridgeway Capital Management, LLC | 0.00% | New | 25,000 | $47K |
| Virtu Financial LLC | 0.00% | New | 21,532 | $40K |
| Stifel Financial Corp. | 0.00% | No change | 15,000 | $28K |
| Full Sail Capital, LLC | 0.00% | New | 10,220 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,550 | $5K |
| Morgan Stanley | 0.00% | Add +24566.7% | 740 | $1K |
| JPMorgan Chase & Co. | 0.00% | New | 322 | $605 |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 100 | $188 |
"% of holder's portfolio" is OSTX's weight in each manager's 13F, not the share of Os Therapies Inc. the manager owns.